Pharmacists in Wells, MN Accepting Medicare
6 Pharmacists found. Showing 1 - 6
 Miss Heather Joline Yennie, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 36 S Broadway, Wells, MN 56097 Phone: 507-553-3161 Fax: 507-553-3914 |
 Richard Alan Mueller Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 36 S Broadway, Wells, MN 56097 Phone: 507-553-3161 Fax: 507-553-3914 |
Ms. Janise Bogenschutz Brindley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 36 So Broadway, Wells, MN 56097 Phone: 507-553-3161 Fax: 507-553-3914 |
Angela Ann Bushlack Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 36 S Broadway, Wells, MN 56097 Phone: 507-553-3161 Fax: 507-553-3914 |
Molly Mcconville, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 36 S Broadway, Wells, MN 56097 Phone: 507-553-3161 |
Katherine Kaufman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 36 S Broadway, Wells, MN 56097 Phone: 507-553-3161 Fax: 507-553-3914 |
News Archive
New spatial index measures connections between poverty and poor accessibility in Brazil
Researchers from the School of Engineering in Trinity College Dublin have developed a new spatial index that measures the connections between poverty and poor accessibility.
Natural painkiller system in the brain responds to social rejection
"Sticks and stones may break my bones, but words will never hurt me," goes the playground rhyme that's supposed to help children endure taunts from classmates. But a new study suggests that there's more going on inside our brains when someone snubs us - and that the brain may have its own way of easing social pain.
Study marks significant milestone for microbicide research field, HIV prevention
Today we congratulate the Centre for the AIDS Programme of Research in South Africa and the people of South Africa on the positive findings from the CAPRISA 004 microbicide study, which marks a significant milestone both for the microbicide research field and HIV prevention as a whole.
AstraZeneca's lawsuit against FDA dismissed without prejudice
AstraZeneca today announced that on March 23, 2012 the US District Court for the District of Columbia issued an opinion and order in AstraZeneca's lawsuit against the US Food and Drug Administration regarding final marketing approval of generic quetiapine. The Court denied the Company's request for a preliminary injunction and dismissed the lawsuit without prejudice.
› Verified 5 days ago